Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Kalvista Pharmaceuticals Inc (KALV)  
$11.41 0.09 (0.78%) as of 4:30 Fri 6/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 56,603,000
Market Cap: 645.84(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $7.4 - $15.39
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 8.4
Insider 6 Months    : 16.1
Insider 3/6 Months : 24.8
Guru Rank Number :  671
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   KalVista Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. Co. has developed a proprietary portfolio of small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema. Co.'s primary focus is on developing oral plasma kallikrein inhibitors for HAE. Co. has developed its candidate sebetralstat into clinical development as a potential oral, on-demand therapy for HAE attacks. Co.'s oral product candidate, KVD824 is also being developed for potential prophylactic treatment of HAE.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 25,000 361,212 361,212 1,612,229
Total Buy Value $235,500 $3,322,934 $3,322,934 $19,435,074
Total People Bought 1 1 1 1
Total Buy Transactions 1 9 9 32
Total Shares Sold 35,430 57,241 139,380 665,223
Total Sell Value $436,961 $666,392 $1,548,075 $8,375,061
Total People Sold 3 3 3 6
Total Sell Transactions 9 15 27 57
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 337
  Page 1 of 14  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Palleiko Benjamin L CHIEF EXECUTIVE OFFICER   •       •      –    2025-06-09 4 S $14.50 $103,951 D/D (7,169) 315,074 23%     
   Palleiko Benjamin L CHIEF EXECUTIVE OFFICER   •       •      –    2025-06-06 4 OE $0.00 $0 D/D 15,625 322,243     -
   Audhya Paul K. CHIEF MEDICAL OFFICER   •       –      –    2025-05-23 4 S $11.31 $24,272 D/D (2,146) 113,026 1%     
   Yea Christopher CHIEF DEVELOPMENT OFFICER   •       –      –    2025-05-23 4 S $11.31 $21,782 D/D (1,926) 98,189 1%     
   Audhya Paul K. CHIEF MEDICAL OFFICER   •       –      –    2025-05-22 4 OE $0.00 $0 D/D 5,000 115,172     -
   Yea Christopher CHIEF DEVELOPMENT OFFICER   •       –      –    2025-05-22 4 OE $0.00 $0 D/D 3,125 100,115     -
   Yea Christopher CHIEF DEVELOPMENT OFFICER   •       –      –    2025-05-22 4 S $11.88 $27,516 D/D (2,317) 96,990 0%     
   Palleiko Benjamin L CHIEF EXECUTIVE OFFICER   •       •      –    2025-05-22 4 S $11.88 $118,743 D/D (9,999) 306,618 0%     
   Audhya Paul K. CHIEF MEDICAL OFFICER   •       –      –    2025-05-22 4 S $11.88 $31,933 D/D (2,689) 110,172 0%     
   Yea Christopher CHIEF DEVELOPMENT OFFICER   •       –      –    2025-05-21 4 OE $0.00 $0 D/D 3,750 99,307     -
   Palleiko Benjamin L CHIEF EXECUTIVE OFFICER   •       •      –    2025-05-21 4 OE $0.00 $0 D/D 23,250 316,617     -
   Audhya Paul K. CHIEF MEDICAL OFFICER   •       –      –    2025-05-21 4 OE $0.00 $0 D/D 6,250 112,861     -
   Audhya Paul K. CHIEF MEDICAL OFFICER   •       –      –    2025-05-19 4 S $11.84 $32,876 D/D (2,776) 106,611 5%     
   Yea Christopher CHIEF DEVELOPMENT OFFICER   •       –      –    2025-05-19 4 S $11.84 $30,791 D/D (2,600) 95,557 5%     
   Palleiko Benjamin L CHIEF EXECUTIVE OFFICER   •       •      –    2025-05-19 4 S $11.84 $45,097 D/D (3,808) 293,367 5%     
   Audhya Paul K. CHIEF MEDICAL OFFICER   •       –      –    2025-05-17 4 OE $0.00 $0 D/D 6,447 109,387     -
   Yea Christopher CHIEF DEVELOPMENT OFFICER   •       –      –    2025-05-17 4 OE $0.00 $0 D/D 4,205 98,157     -
   Palleiko Benjamin L CHIEF EXECUTIVE OFFICER   •       •      –    2025-05-17 4 OE $0.00 $0 D/D 9,364 297,175     -
   Shah Nimish P 10% Owner   –       –       •   2025-04-09 4 B $9.42 $235,500 I/I 25,000 5,303,985 1.5 5%     
   Palleiko Benjamin L CHIEF EXECUTIVE OFFICER   •       •      –    2025-03-07 4 S $11.97 $79,828 D/D (6,669) 287,811 4%     
   Palleiko Benjamin L CHIEF EXECUTIVE OFFICER   •       •      –    2025-03-06 4 OE $0.00 $0 D/D 15,625 294,480     -
   Audhya Paul K. CHIEF MEDICAL OFFICER   •       –      –    2025-02-24 4 S $10.02 $23,988 D/D (2,394) 102,940 -10%     
   Yea Christopher CHIEF DEVELOPMENT OFFICER   •       –      –    2025-02-24 4 S $10.02 $19,218 D/D (1,918) 93,952 -10%     
   Audhya Paul K. CHIEF MEDICAL OFFICER   •       –      –    2025-02-22 4 OE $0.00 $0 D/D 5,000 105,334     -
   Yea Christopher CHIEF DEVELOPMENT OFFICER   •       –      –    2025-02-22 4 OE $0.00 $0 D/D 3,125 95,870     -
  337 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 14
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us